Attachment 32.docx
DOCX document 19 KB Posted
- Attached to
- Occupational Health Services
- Solicitation number
- SP4702-11-R-0001
About this file
Attachment 32
View the file
Other files
Show 40 more
Latest 50 of 56 listed here. See the rest on GovTribe.
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Attachment 32 Mission Essential Services—April 6, 2011
Attachment 32 Mission Essential Services—April 6, 2011
| 0001 |
| Occupational Health Physician Services |
(IAW PWS paragraph 3.1)
| 0001a |
| Additional Occupational Health Physician hours |
(IAW PWS paragraph 3.1)
| 0003 |
| Physical examination (except injuries) |
(IAW PWS paragraphs 3.2.2, 3.2.3, and 3.2.4)
| 0005 |
| Audiograms |
(IAW PWS paragraphs 3.2.2, 3.2.3, and 3.2.4)
| 0006 |
| Masking Audiograms |
(IAW PWS paragraphs 3.2.2 and 3.2.3)
| 0007 |
| Pulmonary Function (FVC, FEV1, FEV1/FVC) |
(IAW PWS paragraphs 3.2.2, 3.2.3. and 3.2.4)
| 0008 |
| EKG |
(IAW PWS paragraphs 3.2.2, 3.2.3. and 3.2.4)
| 0009 |
| Chest X-ray (2 views, “B” reader) |
(IAW PWS paragraphs 3.2.2 and 3.2.3)
| 0014 |
| Blood Lead |
(IAW PWS paragraphs 3.2.2 and 3.2.3)
| 0015 |
| Zinc Protoporphtrin |
(IAW PWS paragraphs 3.2.2 and 3.2.3)
| 0016 |
| Complete Blood Count (including Platelet and Differential) |
(IAW PWS paragraphs 3.2.2, 3.2.3, and 3.2.4)
| 0017 |
| Blood Chemistry (including but not limited to: glucose, BUN, SGOT, creatine, alkaline phosphates, total bilirubin, GGT, cholesterol) |
(IAW PWS paragraphs 3.2.2, 3.2.3, and 3.2.4)
| 0018 |
| Cholinesterase (RBC and serum) |
(IAW PWS paragraphs 3.2.2 and 3.2.3)
| 0019 |
| Carboxyhemoglobin |
(IAW PWS paragraph 3.2.3)
| 0020 |
| Human Immunodeficiency Virus (HIV) blood test |
(IAW PWS paragraph 3.2.4)
| 0021 |
| PPD (Tuberculosis) |
(IAW PWS paragraphs 3.2.2, 3.2.3, and 3.2.4)
| 0022 |
| Urinalysis w/microscopic examination |
(IAW PWS paragraphs 3.2.2, 3.2.3 and 3.2.4)
| 0023 |
| Urinalysis Dip |
(IAW PWS paragraphs 3.2.2, 3.2.3 and 3.2.4)
| 0024 |
| Vision Screening |
(IAW PWS paragraph 3.2.3.4)
| 0025 |
| Cadmium (blood) |
(IAW PWS paragraphs 3.2.2 and 3.2.3)
| 0026 |
| Cadmium (Urine) |
(IAW PWS paragraphs 3.2.2 and 3.2.3)
| 0027 |
| Beta 2 Microglobulin |
(IAW PWS paragraphs 3.2.2 and 3.2.3)
| 0028 |
| Creatinine (Urine) |
(IAW PWS paragraphs 3.2.2 and 3.2.3)
| 0029 |
| Renal Panel |
(IAW PWS paragraphs 3.2.2 and 3.2.3)
| 0030 |
| Pregnancy Test (Urine) |
(IAW PWS paragraph 3.2.4)
| 0031 |
| Malaria Pills – Mefloquine 250 mg (4 tablets)(1 mo supply) |
(IAW PWS paragraphs 3.2.4 and 3.2.5)
| 0032 |
| Malaria Pills – Chloroquine 500 mg (4 tablets) (1 mo supply) |
(IAW PWS paragraphs 3.2.4 and 3.2.5)
| 0033 |
| Malaria Pills – Doxycyline 100 mg (30 capsules) |
(IAW PWS paragraphs 3.2.4 and 3.2.5)
| 0034 |
| Typhoid Vaccine |
(IAW PWS paragraphs 3.2.4 and 3.2.5)
| 0035 |
| Meningococcal Vaccine |
(IAW PWS paragraphs 3.2.4 and 3.2.5)
| 0036 |
| Japanese Encephalitis Vaccine |
(IAW PWS paragraphs 3.2.4 and 3.2.5)
| 0037 |
| Yellow Fever Vaccine |
(IAW PWS paragraphs 3.2.4 and 3.2.5)
| 0038 |
| Hepatitis A Vaccine |
(IAW PWS paragraphs 3.2.3, 3.2.4 and 3.2.5)
| 0039 |
| Hepatitis A Titer |
(IAW PWS paragraphs 3.2.2, 3.2.3, 3.2.4, and 3.2.5)
| 0040 |
| Hepatitis B Vaccine |
(IAW PWS paragraphs 3.2.3, 3.2.4, and 3.2.5)
| 0041 |
| Hepatitis B Titer |
(IAW PWS paragraphs 3.2.2, 3.2.3, 3.2.4, and 3.2.5)
| 0042 |
| Hepatitis C Titer |
(IAW PWS paragraphs 3.2.2, 3.2.3, 3.2.4, and 3.2.5)
| 0043 |
| Varicella Vaccine |
(IAW PWS paragraphs 3.2.3, 3.2.4, and 3.2.5)
| 0044 |
| Varicella Titer |
(IAW PWS paragraphs 3.2.2, 3.2.3, 3.2.4 and 3.2.5)
| 0045 |
| Rubella Titer |
(IAW PWS paragraphs 3.2.2, 3.2.3, 3.2.4 and 3.2.5)
| 0046 |
| Mumps/Measles/Rubella (MMR) Vaccine |
(IAW PWS paragraphs 3.2.3, 3.2.4 and 3.2.5)
| 0048 |
| Polio Vaccine |
(IAW PWS paragraphs 3.2.3, 3.2.4 and 3.2.5)
| 0050 |
| Pre-rabies Vaccine |
(IAW PWS paragraph 3.2.3)
| 0051 |
| Influenza Vaccine |
(IAW PWS paragraphs 3.2.3, 3.2.4 and 3.2.5)
Due to the volatile nature of the influenza vaccine, FOR EVALUATION PURPOSES ONLY, CLIN 0051, above will be evaluated by multiplying the estimated quantity of 2600 ea, times (the evaluation unit price of $15.00, plus an administrative fee per unit proposed by the offeror) to arrive at a total amount for the CLIN.
To be completed by the offeror:
2600 ea X ($15.00 ea plus an administration fee of $_____ per unit) = total amount of $___________________
**The contractor will be paid the quantity actually used for the CLIN times (the unit price of the vaccine actually paid [and verified upon submission of the vaccine invoice] plus the awarded administrative fee per unit.) CLIN 0051 will be funded at the time services are required.
| 0052 |
| Psychiatric Evaluations |
(IAW PWS paragraph 4.3)
| 0053 |
| Health referrals |
(IAW PWS paragraph 4.3)
| 0054 |
| Witness Services |
(IAW PWS paragraph 3.3)
| 0056 |
| Fasting Lipids |
(IAW PWS paragraph 3.2.4)
| 0057 |
| G6PD |
(IAW PWS paragraphs 3.2.4 and 3.2.5)
| 0060 |
| Tetanus Diptheria Vaccine (TDAP) |
(IAW PWS paragraphs 1.7, 3.2.3, 3.2.4 and 3.2.5)
| 0061 |
| HgbA1c |
(IAW PWS paragraphs 3.2.2, 3.2.3 and 3.2.4)
File details come from the government source that posted it. Updated .